News Focus
News Focus
icon url

FALCON1

06/26/20 10:15 PM

#18768 RE: TheHungryHippo #18767

I hope you are right on etheRNA. Isn't IO Biotech a RNA based immuno oncology Co too? I'm just wondering the lack of update with etheRNA as with Imugene before until totally out of the picture. I wish Mr. Kempers will make a change in his way in communicating with us shareholders. :(


regards,
icon url

Work Harder

06/28/20 4:48 PM

#18782 RE: TheHungryHippo #18767

Well, wadda ya know

Like I said Brother gotta be some kinda otc derivatives in here somewhere

Pieter Leentvaar

Global Program Manager at Catalent Pharma Solutions

Legal & Finance Associate

ANERGIS The Future of Allergy Treatment: Ultra-Fast Desensitization

Juni 2014 – Nov. 2015 1 Jahr 6 Monate

Lausanne Area, Switzerland

All Options Helvetia AG
1 Jahr 11 Monate

Senior Equity Derivatives Trader

Okt. 2007 – Sep. 20081 Jahr

Zug, Switzerland

Starting up a Swiss trading team

Marketmaker in Swiss single stock options

Equity Derivatives Trader
Nov. 2006 – Okt. 20071 Jahr

Amsterdam Area, Netherlands

Marketmaker in single stock options German market

Derivatives and cash trader
Optiver Holding BV
Nov. 1997 – Apr. 20024 Jahre 6 Monate

Amsterdam Area, Netherlands

Marketmaker in single stock options both on Amsterdam trading floor and through screen trading
Cross border and currency volatility arbitrage
Stock arbitrage
ETF arbitrage


https://ch.linkedin.com/in/pieter-leentvaar-5780197?challengeId=AQFPXcdtqrXbHwAAAXL8qGYt7QRWxugrxhj6i5hen2CgL34c2APo8xiY3QsokUiE7VARoM_8t2N5Y3e3gzUVm-dK-u4-8o6pLA&submissionId=0a19db75-c0cf-1c16-f2c0-7bc891c9474e

This thing better be on the up & up

.......

!!!!!!!!!